FormWeb • midostaurin

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

midostaurin

midostaurin

Restricted Rydapt --> restricted to oncology for low income patients undergoing AML induction therapy, or in situations where outpatient supply would delay start date.

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Rydapt	CAPSULE, ORAL	25 mg

Comments:

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Rydapt is restricted to oncology for low income patients undergoing AML induction therapy, or in situations where outpatient supply would delay start date. Patient should use own supply. Can be filled by CCI or HH outpatient pharmacy for inpatient use.

Reviewed: 24 Oct 2017 (Rydapt)

Last updated: Jun. 28, 2022

HAZ-MED: Group 1
Chemotherapy:
Formulary, Not Routinely Stocked: Rydapt --> 25 mg capsule

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.